Puma Biotechnology Q3 Adj. EPS $0.15 Beats $0.11 Estimate, Sales $55.100M Miss $57.424M Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings BeatsEarnings Misses
Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.11 by 36.36 percent. This is a 28.57 percent decrease over earnings of $0.21 per share from
Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.11 by 36.36 percent. This is a 28.57 percent decrease over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $55.100 million which missed the analyst consensus estimate of $57.424 million by 4.05 percent. This is a 1.10 percent increase over sales of $54.500 million the same period last year.